Serum ferritin, iron and transferrin in women with thyrotoxic Graves' disease before and after methimazole treatment.
We investigated iron metabolism in 47 women with thyrotoxic Graves' disease. Serum iron, ferritin, transferrin, triiodothyronine and thyroxine concentrations were RIA measured before and after methimazole treatment when patients became euthyroid. The control group consisted of 52 healthy women. We noted that serum ferritin levels and the ferritin to transferrin ration were significantly lower while the iron to ferritin ratio was higher in patients before and after methimazole therapy. Iron concentration as well as the iron to transferrin and the iron to thyroid hormone ratios were decreased only before treatment.
Zwirska-Korczala
K
K
Department of Pathophysiology and Clinical Analytics Silesian Medical Academy, Zabrze, Poland.
Buntner
B
B
Sobieraj
H
H
Ostrowska
Z
Z
Kniazewski
B
B
Swietochowska
E
E
D000328:Adult; D005260:Female; D005293:Ferritins / Q000097:blood*; D006111:Graves Disease / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D007501:Iron / Q000097:blood*; D008713:Methimazole / Q000494:pharmacology* / Q000627:therapeutic use; D011863:Radioimmunoassay; D013974:Thyroxine / Q000097:blood; D014168:Transferrin / Q000032:analysis*; D014284:Triiodothyronine / Q000097:blood
D014168:Transferrin; D014284:Triiodothyronine; D008713:Methimazole; D005293:Ferritins; D007501:Iron; D013974:Thyroxine